FEXERIC

This brand name is authorized in Austria, Estonia, Ireland, Lithuania, Poland

Active ingredients

The drug FEXERIC contains one active pharmaceutical ingredient (API):

1 Iron(III) citrate
UNII 63G354M39Z - FERRIC CITRATE ANHYDROUS

Ferric citrate is a phosphate binder and iron replacement product. It is used for the control of serum phosphorus levels and the treatment of iron deficiency anemia in adult patients with chronic kidney disease on dialysis.

Read about Ferric citrate

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FEXERIC Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia V Various → V03 All other therapeutic products → V03A All other therapeutic products
Discover more medicines within V03AE

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1697979
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1078391
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100355711

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.